Skip to content
LexBuild

Drug Safety and Risk Management Advisory Committee; Notice of Postponement

---
identifier: "/us/fr/03-25449"
source: "fr"
legal_status: "authoritative_unofficial"
title: "Drug Safety and Risk Management Advisory Committee; Notice of Postponement"
title_number: 0
title_name: "Federal Register"
section_number: "03-25449"
section_name: "Drug Safety and Risk Management Advisory Committee; Notice of Postponement"
positive_law: false
currency: "2003-10-08"
last_updated: "2003-10-08"
format_version: "1.1.0"
generator: "[email protected]"
agency: "Health and Human Services Department"
document_number: "03-25449"
document_type: "notice"
publication_date: "2003-10-08"
agencies:
  - "Health and Human Services Department"
  - "Food and Drug Administration"
fr_citation: "68 FR 58116"
fr_volume: 68
fr_action: "Notice."
---

#  Drug Safety and Risk Management Advisory Committee; Notice of Postponement

**AGENCY:**

Food and Drug Administration, HHS.

**ACTION:**

Notice.

**SUMMARY:**

The Food and Drug Administration (FDA) is postponing the meeting of the Drug Safety and Risk Management Advisory Committee scheduled for September 19, 2003, due to Hurricane Isabel. The future date of this meeting is to be determined. This meeting was announced in the *Federal Register* of August 5, 2003 (68 FR 46199).

**FOR FURTHER INFORMATION CONTACT:**

Shalini Jain, Center for Drug Evaluation and Research (HFD-21), Food and Drug  Administration, 5600 Fishers Lane (for express delivery, 5630 Fishers Lane, rm. 1093), Rockville, MD 20857, 301-827-7001, FAX: 301-827-6776, or e-mail: *[email protected]* , or FDA Advisory Committee Information Line, 1-800-741-8138 (301-443-0572 in the Washington, DC area), code 12535. Please call the Information Line for up-to-date information on this meeting.

Dated: October 2, 2003.

Peter J. Pitts,

Associate Commissioner for External Relations.